We introduce pinta, a pipeline for reducing the upgraded Giant Metre-wave Radio Telescope (uGMRT) raw pulsar timing data, developed Indian Pulsar Timing Array experiment. provide detailed description of workflow and usage as well its computational performance RFI mitigation characteristics. also discuss novel independent determination relative time offsets between different back-end modes uGMRT...

in this study the genetic polymorphism of growth hormone (gh) gene as a candidate gene in livestock was investigated. blood samples were randomly collected from 34 alpine and 42 saanen goats. dna was extracted from blood samples and a 365 bp region of exon 5 of the gh genewas amplified by polymerase chain reaction (pcr). pcr products were analyzed using single strand conformation polymorphism (...

Proof. We consider the two cases: either g ∈ H or g ∈ G−H. Case 1 Suppose g ∈ H. Then for any gh ∈ gH, gh ∈ H. This implies gH ⊆ H. Now, let h be any element of H. Then h = (gg−1)h = g(g−1h), and g−1h ∈ H because g−1 and h are both in the subgroup H. It follows that h ∈ gH and H ⊆ gH. Therefore, gH = H. It can be similarly shown that Hg = H. This means gH = Hg and H £ G by Lemma 2.5.1 from clas...

Objective(s) The immunoadjuvant potential of cross-linked dextran microspheres (CDM) as absorption enhancer and Quillaja saponins (QS) as immunomodulator adjuvant was evaluated. Materials and Methods CDM loaded or tetanus-mixed toxoid (TT) or Quillaja saponin (QS) were nasally administered to rabbits in dry powder form, three times in 2 weeks interval and serum IgG and nasal lavage sIgA tite...

there are numerous, often contradictory reports on the effect of growth hormone (gh) therapy on thyroid function. these reports prompted us to evaluate the impact of gh therapy on thyroid function in previously euthyroid children with gh deficiency. twenty five clinically and biochemically euthyroid children with gh deficiency were studied. a thyroid profile (t4, free t4, t3 and tsh) was perfor...

Recombinant human growth hormone (hGH) was given for 6 months or longer to 68 patients with GH deficiency, 6 with Turner's syndrome and 5 with achondroplasia, during 1986-1994 in a prospective study. The total weekly administered dose of GH was 0.6 u/kg. By random sampling, 29 of 68 GH deficient patients (42.6%) received twice weekly (2 iw) intramuscular (im) injections, 17 (25%) received ...

BACKGROUND The group A meningococcal conjugate vaccine, PsA-TT, uses tetanus toxoid (TT) as a carrier protein (PsA-TT). TT as a carrier protein in other conjugate vaccines is known to be immunogenic and generates a robust anti-TT response. METHODS Clinical studies in Africa assessed whether PsA-TT generated tetanus serologic responses when tested in African populations (toddlers to adults). S...

introduction and aims: tt virus (ttv) is a dna virus and is proposed as a potential cause of non-a to e hepatitis. we aimed to investigate, for the first time, the prevalence of ttv in iranian healthy blood donors. materials and methods: three hundred and twelve healthy iranian blood donors were randomly selected and tested for ttv dna by the seminested polymerase chain reaction method. serum a...

background: in 1997, a novel dna virus was isolated from the serum of a patient in japan